Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
Drinking with hepatitis B is a dangerous combo for liver cancer risk. A new study found that heavy alcohol consumption quadruples the risk of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B — and that's true whether or not they have cirrhosis. Researchers say systematic alcohol screening and reduction should be a priority for this patient population.
A new retrospective cohort study out of China adds important clarity to a long-standing question: just how much does alcohol amplify liver cancer risk in people already living with chronic hepatitis B (CHB)? The answer — a lot. Researchers tracked 1,010 CHB patients over nearly 3,700 person-years and found that alcohol consumption independently and significantly raised the risk of hepatocellular carcinoma (HCC), regardless of whether patients also had liver cirrhosis.
The findings are a wake-up call for clinicians managing CHB patients. The risk wasn't just elevated — it was dramatically so for heavy drinkers, and the dose-response relationship was clear across all subgroups analyzed.
By the Numbers:
Why it matters: Alcohol is a modifiable risk factor. For the hundreds of millions of people worldwide living with CHB, these findings underscore that cutting back on drinking isn't just lifestyle advice — it could be life-saving. Clinicians should routinely assess and counsel CHB patients on alcohol use as a core part of HCC prevention.
